Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Assisted reproductive technologies in Latin America: the Latin American Registry, 2019
Indexado
WoS WOS:000970025400013
Scopus SCOPUS_ID:85139439084
DOI 10.5935/1518-0557.20220034
Año 2022
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Research question: What was the utilization, effectiveness and safety of assisted reproductive technology (ART) in Latin America during 2019? Design: This was a retrospective collection of multinational data on ART performed at 196 institutions from 15 countries. Results: A total of 106,918 initiated cycles, 18,133 deliveries and 21,096 births were reported. ART utilization was 24–558 cycles per million inhabitants. Women aged ≥40 years represented 32.9% of fresh IVF and intracytoplasmic sperm injection (ICSI) cycles. After removing freeze-all cycles, the delivery rate per oocyte retrieval was 17.3% for ICSI and 19.5% for IVF. Overall, single-embryo transfer (SET) represented 36.2% of fresh transfers, with a 19.5% delivery rate per transfer, increasing to 30.7% for elective SET and 32.7% for blastocyst elective SET (eSET). The delivery rate for double-embryo transfers (DET) was 27.8%, increasing to 37.1% after elective DET. This 6.4% increment in deliveries between eSET and elective DET resulted in a 12-fold increase in twin births. Furthermore, overall perinatal mortality was more than two-fold higher for twin compared with singleton deliveries. The delivery rate for frozen-thawed SET reached 28.1%, most being blastocyst transfers. Of all births, 72.3% were singletons, 26.4% twins and 1.3% triplets and higher multiples. Preterm deliveries reached 14.3% for singletons and 58.1% for twins. Perinatal mortality was 7.4‰ in singletons, 17.2‰ for twins and 62.9‰ for triplets or higher. Conclusions: The number of initiated cycles has slowly increased in countries with laws or regulations facilitating access. FET cycles predominate and blastocyst SET are also increasing. The data show that, especially in young women and oocyte recipients, when there is more than one blastocyst for transfer, eSET should be the rule.

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Obstetrics & Gynecology
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Zegers-Hochschild, Fernando Hombre Clínica Las Condes - Chile
Facultad de Medicina - Chile
Universidad Diego Portales - Chile
2 Crosby, Javier Hombre Clínica Las Condes - Chile
3 Musri, Carolina Mujer Clínica Las Condes - Chile
4 Souza, Maria do Carmo B. Mujer Fertipraxis - Brasil
5 Martinez, A. Gustavo - Fertilis - Argentina
5 Martinez, A. Gustavo - Fertilis - Argentina
6 Silva, Adelino Amaral Hombre SHLS cj L - Brasil
7 Mojarra, Jose Maria Hombre Hospital CIMA Hermosillo - México
Hosp CIMA Hermosillo - México
7 Mojarra, José María - Hospital CIMA Hermosillo - México
8 Masoli, Diego Hombre Clínica Las Condes - Chile
9 Posada, Natalia Mujer INSER - Colombia
10 Latin Amer Network Assisted Reprod Corporación Latin Amer Network Assisted Reprod REDLARA - Uruguay

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
Sin Información

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
The authors gratefully acknowledge all centres that voluntarily report their data year on year to the Latin American Registry of ART. They also thank Ferring Pharmaceuticals for their generosity and continuous support to the Registry and to Kurt Schwarze for the development and permanent updating of the cycle-based regional registry.

Muestra la fuente de financiamiento declarada en la publicación.